(Q84190335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Lars Harbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Marion J Pollheimer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Thomas Bauernhofer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Peter Kornprat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Richard A Lindtner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Andrea Schlemmer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Peter Rehak

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Cord Langner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

7 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

961-971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20453834%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.83

2 February 2020

exact match

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

New therapies for GI cancers fall short

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Mesorectal excision for rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Treatment in advanced colorectal cancer: what, when and how?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

EGFR antagonists in cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Expression of prolactin and its receptor in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Prolactin involvement in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Rational design of competitive prolactin/growth hormone receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Therapeutic potential of S179D prolactin--from prostate cancer to angioproliferative disorders: the first selective prolactin receptor modulator

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Development and potential clinical uses of human prolactin receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Interrelationship of prolactin and its receptor in carcinoma of colon and rectum: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Ectopic production of prolactin by colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Expression of functional prolactin and its receptor in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

AgarCyto: a novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Lack of association between hyperprolactinemia and colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Plasma and tumor prolactin in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Complex prolactin crosstalk in breast cancer: new therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Development of pure prolactin receptor antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021

Development of a prolactin receptor-targeting fusion toxin using a prolactin antagonist and a recombinant form of Pseudomonas exotoxin A.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.83

7 January 2021